Health & Personal Care
HIGH
FDA DRUG
Ascend Laboratories Recalls Aripiprazole Tablets Due to Potency Risk
Ascend Laboratories, LLC recalled 2,256 bottles of Aripiprazole Tablets on August 28, 2025. The recall followed reports that the drug may be superpotent, posing serious health risks. Consumers should stop using the product immediately and consult healthcare providers.
ARIPIPRAZOLE
Superpotent drug